Search Within

Mark Musa Souweidane

  1. "Kim Kramer"
  2. "Ira Dunkel"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (6)
Groups
  1. Neuro-Oncology Service (18)
  2. Pediatrics, Department of (18)
  3. Survivorship Research (18)
  4. GSK Faculty (15)
  5. Radiology, Department of (15)
  6. Tow Center for Developmental Oncology (TCDO) (14)

More Groups

People
  1. Ira Dunkel (18)
  2. Kim Kramer (18)
  3. Yasmin Khakoo (13)
  4. Steven Larson (12)
  5. Nai-Kong Cheung (11)
  6. Sofia Haque (11)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (2)
  4. 2019 (1)
  5. 2018 (1)
  6. 2017 (2)

More Years

Publications
  1. Neuro-Oncology (9)
  2. Journal of Clinical Oncology (4)
  3. International Journal of Radiation Oncology, Biology, Physics (1)
  4. Journal of Hematology & Oncology (1)
  5. Lancet Oncology (1)
  6. Medical and Pediatric Oncology (1)

More Publications

Publishers
  1. Oxford University Press (9)
  2. American Society of Clinical Oncology (4)
  3. Biomed Central Ltd (1)
  4. Elsevier Inc. (1)
  5. Elsevier Science, Inc. (1)
  6. Wiley Liss (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Craniospinal radiation therapy may not be necessary for localized nongerminomatous germ cell tumors (NGGCT)
    Meeting Abstract

    Cahlon, O.; Dunkel, I.; Gilheeney, S.; Khakoo, Y.; Souweidane, M.; De Braganca, K.; Kramer, K.; Wolden, S.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Marker (+) CNS germ cell tumors in remission: Are surveillance MRI scans necessary?
    Journal Article

    Martinez, S.; Khakoo, Y.; Gilheeney, S.; Kramer, K.; Wolden, S.; Souweidane, M.; Dunkel, I. J.
    Pediatric Blood and Cancer (2014)

    Fulltext@MSK | Save
  • Radioimmunotherapy for high-risk and recurrent central nervous system (CNS) cancers: Results of a phase II study with intra-ommaya I-131-3f8
    Meeting Abstract

    Kramer, K.; Smith-Jones, P. M.; Humm, J. L.; Zanzonico, P. B.; Pandit-Taskar, N.; Carrasquillo, J. A.; Modak, S.; Tickoo, S.; Gerald, W. L.; Dunkel, I. J.; more...
    Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • Treatment strategies for recurrent medulloblastoma - Report of a single institution experience
    Meeting Abstract

    Gilheeney, S. W.; McLaren, S.; Dreyfuss, H.; Becher, O. J.; Khakoo, Y.; Kramer, K.; Lyden, D. C.; Souweidane, M.; Wolden, S.; Dunkel, I. J.
    Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • A trial of intra-ommaya (IO) radioimmunotherapy (Rit), reduced-dose external beam craniospinal radiotherapy (Rt) with intensity-modulated radiotherapy (IMRt) boost, and chemotherapy for patients with standard-risk medulloblastoma
    Meeting Abstract

    Dunkel, I. J.; Wolden, S. L.; Souweidane, M. M.; Sklar, C. A.; Khakoo, Y.; Larson, S. M.; Becher, O. J.; Gershon, T. R.; Gilheeney, S. W.; Lyden, D. C.; more...
    Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8
    Journal Article

    Kramer, K.; Humm, J. L.; Souweidane, M. M.; Zanzonico, P. B.; Dunkel, I. J.; Gerald, W. L.; Khakoo, Y.; Yeh, S. D.; Yeung, H. W.; Finn, R. D.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Intrathecal 131-I-labeled 3F8 antibody in patients with GD2-expressing central nervous system and leptomeningeal neoplasms
    Meeting Abstract

    Kramer, K.; Cheung, N. K. V.; Humm, J.; Yeh, S.; Dantis, E.; Dunkel, I. J.; Wolden, S.; Finn, R.; Kushner, B. H.; Khakoo, Y.; more...
    Neuro-Oncology (2004)

    Fulltext@MSK | Save
  • Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8
    Journal Article

    Kramer, K.; Cheung, N. K. V.; Humm, J. L.; Dantis, E.; Finn, R.; Yeh, S. J.; Antunes, N. L.; Dunkel, I. J.; Souweidane, M.; Larson, S. M.
    Medical and Pediatric Oncology (2000)

    Fulltext@MSK | Save